Concentric Exercise Effects on Skeletal Muscle Water T2 in Duchenne Muscular Dystrophy (P2.131)

Ami Mankodi,Noura Azzabou,Thomas Bulea,Harmen Reyngoudt,Hirity Shimellis,Yupeng Ren,Eunhee Kim,Kenneth Fischbeck,Pierre Carlier

DOI: https://doi.org/10.1212/wnl.88.16_supplement.p2.131

IF: 9.9

2017-01-01

Neurology

Abstract:Objective: To examine the concentric ankle dorsiflexion exercise effects on the magnetic resonance imaging (MRI) measure of muscle water T 2 in the lower legs of patients with Duchenne muscular dystrophy (DMD). Background: Surrogate outcome measures are needed to measure therapeutic response in clinical trials of DMD. Absence of dystrophin leads to sarcolemmal fragility with consequent more susceptibility to damage following eccentric exercise. Active movement training can lead to functional improvements. However, the effects of submaximal concentric muscle activity on DMD muscle are not yet known. MRI water T 2 is sensitive to changes of muscle injury or edema, but fatty replacement masks increases in water T 2 in human dystrophic muscle. The tri-exponential model measures muscle water T 2 independent of fat values in skeletal muscle. Design/Methods: In 12 ambulatory DMD boys and 19 healthy volunteer boys, muscle water T 2 was measured at baseline and 3h post concentric ankle dorsiflexion exercise in the lower leg muscles by the tri-exponential model. Muscle fat fraction (FF) was measured by Dixon. Results: The muscle FF was higher in nearly all of the lower leg muscles of DMD participants than the healthy volunteers ( p T 2 was higher in the lower leg muscles of DMD participants than the healthy volunteers ( p p T 2 increased from baseline in the lower legs of both groups. Most prominent T 2 increases were in the ankle dorsiflexor muscles of the DMD participants with a larger inter-subject variability than the healthy volunteers. Conclusions: Skeletal muscle water T 2 measured by the tri-exponential model is a sensitive MRI biomarker related to muscle degeneration and concentric muscle exercise in DMD. Study Supported by: NIH Intramural Funds Disclosure: Dr. Mankodi has nothing to disclose. Dr. Azzabou has nothing to disclose. Dr. Bulea has nothing to disclose. Dr. Reyngoudt has nothing to disclose. Dr. Shimellis has nothing to disclose. Dr. Ren has received personal compensation for activities with RehabTek, Inc., as an employee. Dr. Kim has nothing to disclose. Dr. Fischbeck has nothing to disclose. Dr. Carlier has nothing to disclose.